Trials / Active Not Recruiting
Active Not RecruitingNCT04789018
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology ENGAGEMENT Study (Virtual Genetics Board)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 118 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.
Detailed description
PRIMARY OBJECTIVE: I. To assess perceived usefulness of a virtual genetics board. SECONDARY OBJECTIVE: I. To assess acceptability/feasibility, perceived ease of use, self-efficacy for recommendations, genetics knowledge. OUTLINE: Participants complete a survey about genetic knowledge and self efficacy and then attend virtual genetics board. After virtual genetics board meeting, participants complete a second survey about perceived usefulness, ease of use, acceptability, feasibility, self-efficacy and genetic knowledge. Participants may also complete a semi-structured interview after virtual genetics board.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational Intervention | Attend virtual genetics board |
| OTHER | Survey Administration | Complete survey |
| OTHER | Interview | Complete interview |
Timeline
- Start date
- 2020-01-21
- Primary completion
- 2026-06-24
- Completion
- 2026-06-24
- First posted
- 2021-03-09
- Last updated
- 2025-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04789018. Inclusion in this directory is not an endorsement.